The European Medicines Agency (EMA) has recommended granting marketing authorization in the EU for brensocatib (Brinsupri, ...
The European medicines regulator said that a higher rate of death and disease complications in recent trials meant the ...
DPA International on MSN
European lawmakers call for male contraceptive pill
Peter Liese and Katarina Barley are pushing for more relaxed approval regulations for male contraceptives in a letter to the ...
The Israel-based company, which developed Elfabrio alongside Chiesi Global Rare Diseases, part of Italy-based Chiesi Group, had been seeking approval for a new, less frequent dosing regimen for ...
Novo Nordisk announced that the European Medicines Agency (EMA) has approved an update to the label for Rybelsus (oral semaglutide).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback